Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab182916-100μg
|
100μg |
10
|
$109.90
|
|
|
Ab182916-1mg
|
1mg |
4
|
$519.90
|
|
|
Ab182916-5mg
|
5mg |
1
|
$1,399.90
|
|
|
Ab182916-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,239.90
|
|
Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Quavonlimab (anti-CTLA-4) - Primary antibody, specific to CTLA4, Human IgG1, INHIBITOR of Cytotoxic T-lymphocyte protein 4 inhibitor |
|---|---|
| Synonyms | ALPS5 antibody | CD 152 antibody | CD antibody | CD152 antibody | CD152 antigen antibody | CD152 isoform antibody | Celiac disease 3 antibody | CELIAC3 antibody | CTLA 4 antibody | CTLA-4 antibody | CTLA4 antibody | CTLA4_HUMAN antibody | Cytotoxic T cell |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | CTLA4 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Cytotoxic T-lymphocyte protein 4 inhibitor |
| Product Description |
Quavonlimab (anti-CTLA-4) is a novel anti-CTLA-4 antibody. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 145 kDa |
| Purification Method | Protein A purified |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 2254059-25-9 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Quavonlimab (anti-CTLA-4) (Ab182916) - ELISA
Immobilized Recombinant Human Human CTLA-4 protein (rp176276) at 1.0 μg/mL can bind Quavonlimab (anti-CTLA-4) (Ab182916) with the EC50 of 12.98 ng/mL.
Quavonlimab (anti-CTLA-4) (Ab182916) - SEC
The purity of Quavonlimab (anti-CTLA-4) (Ab182916) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jul 24, 2024 | Ab182916 | |
| Certificate of Analysis | Jul 24, 2024 | Ab182916 | |
| Certificate of Analysis | Jul 24, 2024 | Ab182916 |
Starting at $79.90
Starting at $69.90
Starting at $39.90